{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:11:07Z","timestamp":1789038667818,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08403-5","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:43:03Z","timestamp":1789036983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-3814","authenticated-orcid":false,"given":"Ciro","family":"Manzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-2055","authenticated-orcid":false,"given":"Alberto","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"10411","key":"8403_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","volume":"402","author":"G Esp\u00edgol-Frigol\u00e9","year":"2023","unstructured":"Esp\u00edgol-Frigol\u00e9 G, Dejaco C, Mackie SL, Salvarani C, Matteson EL, Cid MC (2023) Polymyalgia rheumatica. Lancet 402(10411):1459\u20131472. https:\/\/doi.org\/10.1016\/S0140-6736(23)01310-7","journal-title":"Lancet"},{"issue":"5","key":"8403_CR2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","volume":"0","author":"A Sharma","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum 0(5):1040\u20131048. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"8403_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7090092","volume":"7","author":"C Manzo","year":"2019","unstructured":"Manzo C (2019) Incidence and prevalence of polymyalgia rheumatica (PMR): the importance of the epidemiological context. The Italian case. Med Sci 7:92. https:\/\/doi.org\/10.3390\/medsci7090092","journal-title":"Med Sci"},{"key":"8403_CR4","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2147\/CIA.S549148","volume":"20","author":"X Quiao","year":"2025","unstructured":"Quiao X, Chen X, Wang W et al (2025) Classification of elderly patients with comorbidities and their subtypes: a data-driven cluster analysis. Clin Interv Aging 20:1671\u20131680. https:\/\/doi.org\/10.2147\/CIA.S549148","journal-title":"Clin Interv Aging"},{"issue":"7","key":"8403_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s11606-024-08631-y","volume":"39","author":"KL Sheu","year":"2024","unstructured":"Sheu KL, Chen CC, Chen SC (2024) Impact of comorbidities on the risk of polypharmacy and potentially inappropriate medications in older patients. J Gen Intern Med 39(7):1270\u20131271. https:\/\/doi.org\/10.1007\/s11606-024-08631-y","journal-title":"J Gen Intern Med"},{"issue":"30","key":"8403_CR6","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/RHU.0000000000001969","volume":"1","author":"JP Vinicki","year":"2024","unstructured":"Vinicki JP, Gut O, Maliandi MDR et al (2024) Risk factors for relapse and\/or prolonged glucocorticoid therapy in polymyalgia rheumatica: multicenter study in 185 patients. J Clin Rheumatol 1(30):e34\u2013e38. https:\/\/doi.org\/10.1097\/RHU.0000000000001969","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"8403_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105680","volume":"91","author":"Y Tanaka","year":"2024","unstructured":"Tanaka Y, Tanaka S, Fukasawa T, Inokuchi S, Uenaka H, Kimura T et al (2024) Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: a cohort study using routinely collected health data. Jt Bone Spine 91(3):105680. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105680","journal-title":"Jt Bone Spine"},{"issue":"3","key":"8403_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkad095","volume":"7","author":"C Chatzigeorgiou","year":"2023","unstructured":"Chatzigeorgiou C, Taylor JC, Elliott F et al (2023) Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank. Rheumatol Adv Pract 7(3):rkad095. https:\/\/doi.org\/10.1093\/rap\/rkad095","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"8403_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/life12070985","volume":"12","author":"C Manzo","year":"2022","unstructured":"Manzo C, Milchert M, Venditti C et al (2022) Fever correlation with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentrations in patients with isolated polymyalgia rheumatica (PMR): a retrospective comparison study between hospital and out-of-hospital local registries. Life (Basel) 12(7):985. https:\/\/doi.org\/10.3390\/life12070985","journal-title":"Life (Basel)"},{"issue":"5","key":"8403_CR10","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1093\/rheumatology\/keae531","volume":"64","author":"S Cowley","year":"2025","unstructured":"Cowley S, Harkins P, Kirby C et al (2025) Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic. Rheumatology (Oxford) 64(5):3006\u20133011. https:\/\/doi.org\/10.1093\/rheumatology\/keae531","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8403_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et al (2015) 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74(10):1799\u20131807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"key":"8403_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.semarthrit.2020.05.003","volume":"50","author":"R Partington","year":"2020","unstructured":"Partington R, Muller S, Mallen CD et al (2020) Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study. Semin Arthritis Rheum 50:663\u2013672. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.003","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8403_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s40744-025-00797-z","volume":"12","author":"P Harkins","year":"2025","unstructured":"Harkins P, Cowley S, Burke E et al (2025) Modern management of isolated polymyalgia rheumatica. Rheumatol Ther 12(6):1017\u20131041. https:\/\/doi.org\/10.1007\/s40744-025-00797-z","journal-title":"Rheumatol Ther"},{"key":"8403_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1080\/14712598.2023.228709","volume":"12","author":"D Wendling","year":"2023","unstructured":"Wendling D (2023) Biological therapy in polymyalgia rheumatica. Expert Opin Biol Ther 12:1255\u20131263. https:\/\/doi.org\/10.1080\/14712598.2023.228709","journal-title":"Expert Opin Biol Ther"},{"key":"8403_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1532-5415.1993.tb05945.x","volume":"41","author":"Y Conwell","year":"1993","unstructured":"Conwell Y, Forbes NT, Cox C, Caine ED (1993) Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc 41:38\u201341. https:\/\/doi.org\/10.1111\/j.1532-5415.1993.tb05945.x.","journal-title":"J Am Geriatr Soc"},{"key":"8403_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-n","volume":"41","author":"MD Miller","year":"1992","unstructured":"Miller MD, Paradis CF, Houck PR et al (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237\u2013248. https:\/\/doi.org\/10.1016\/0165-1781(92)90005-n","journal-title":"Psychiatry Res"},{"issue":"71","key":"8403_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"2012","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Ma C, Hm K et al (2012) Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology Collaborative Initiative. Ann Rheum Dis 2012(71):484\u2013492. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8403_CR18","doi-asserted-by":"publisher","first-page":"030","DOI":"10.23937\/2469-5858\/1510030","volume":"3","author":"KP Osborn IV","year":"2017","unstructured":"Osborn KP IV, Nothelle S, Slaven JE et al (2017) Cumulative Illness Rating Scale (CIRS) can be used to predict hospital outcomes in older adults. J Geriatr Med Gerontol 3(2):030. https:\/\/doi.org\/10.23937\/2469-5858\/1510030","journal-title":"J Geriatr Med Gerontol"},{"key":"8403_CR19","doi-asserted-by":"publisher","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S,\u00a0et al (2000) Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 908:244\u201354. https:\/\/doi.org\/10.1111\/j.1749-6632. 2000.tb06651. x.","DOI":"10.1111\/j.1749-6632"},{"issue":"1","key":"8403_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard-2022-223429","volume":"83","author":"C Dejaco","year":"2024","unstructured":"Dejaco C, Kerschbaumer A, Alehata D et al (2024) Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis 83(1):48\u201357. https:\/\/doi.org\/10.1136\/ard-2022-223429","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08403-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:43:04Z","timestamp":1789036984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08403-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":20,"alternative-id":["8403"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08403-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Given the strictly retrospective, fully anonymized, and pseudonymous nature of this routine clinical chart review, a formal institutional protocol waiver for standard ethical approval and patient informed consent was implemented. This approach is in full compliance with the competent institutional review guidelines (Azienda Sanitaria Locale Napoli 3 sud and Azienda Provinciale Catanzaro Medical Directions) and national data protection regulations governing real-world observational research and registry-derived data. Absolute identity protection and patient privacy were strictly maintained throughout the entire data aggregation process.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No part of this manuscript is copied, submitted, or published elsewhere. All authors take full responsibility for the integrity and accuracy of all aspects of the work. AI was not used to write this manuscript.","order":3,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}